Source: Nasdaq

Sagent: Sagent Pharma Recalls Chemotherapy Drug Docetaxel Injection

(RTTNews) - Sagent Pharmaceuticals has recalled two lots of chemotherapy drug Docetaxel Injection, USP due to potential presence of particulate matter from the stopper in the drug, according to the U.S. Food and Drug Administration.

Read full article »
Est. Annual Revenue
$100-500M
Est. Employees
250-500
Peter Kaemmerer's photo - CEO of Sagent

CEO

Peter Kaemmerer

CEO Approval Rating

68/100

Read more